Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00463203
Recruitment Status : Completed
First Posted : April 20, 2007
Last Update Posted : June 29, 2011
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2011
  Study Completion Date : June 2011